Vote Scores

Home / Companies / Rhythm Pharmaceuticals, Inc. / 24 Jun 2026

Meeting · year to 30 June 2026461 filers reporting

Rhythm Pharmaceuticals, Inc.: meeting of 24 Jun 2026

Votes reported on Form N-PX, item by item

461 Form N-PX filers reported votes at the Rhythm Pharmaceuticals, Inc. meeting of 24 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 75.2% of reported votes for; 75 filers withheld from or voted against at least one nominee.

636 vote records from 168 filers. 8 of the 167 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

62.5% for0.0% against37.5% other4.8% against management168 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

684 vote records from 460 filers. 193 of the 444 filers that marked the item either way voted against management. 16 filers reported this item without a management mark.

54.1% for41.5% against4.3% other43.5% against management460 filers80.9% for19.1% against0.1% other19.2% against management84,981,486 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

318 vote records from 168 filers. 1 of the 167 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

98.8% for0.0% against1.2% other0.6% against management168 filers99.9% for0.0% against0.1% other0.1% against management27,195,334 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalNo reportAgainst *No report
State Street and SPDRForForFor
American CenturyNo reportAgainst *No report
Franklin TempletonAbstain or withhold *Against *For
InvescoForAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsSplit or no voteAgainst *For
John Hancock and ManulifeAbstain or withhold *Against *For
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *Against *For
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesSplit or no voteAgainst *For
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaSplit or no voteForFor
First TrustSplit or no voteAgainst *For
Russell InvestmentsForForFor
NationwideForForFor
Victory CapitalSplit or no voteAgainst *For
Brighthouse FundsForForFor
Guggenheim and RydexSplit or no voteAgainst *For
Columbia ThreadneedleForAgainst *For
BNY MellonForAgainst *For
PrincipalSplit or no voteForFor
Capital Group and American FundsForAgainst *For
Pacific Life fundsForForFor
Global XForForFor
TransamericaForForFor
Federated HermesForForFor
AllianceBernsteinSplit or no voteForFor
DWSSplit or no voteAgainst *For
AllspringSplit or no voteSplit or no voteSplit or no vote
MassMutualForAgainst *For
Harbor FundsForAgainst *For
VirtusSplit or no voteAgainst *For
Janus HendersonForForFor
Neuberger BermanForForFor
Natixis and Loomis SaylesForForFor
Lord AbbettSplit or no voteForFor
Artisan PartnersNo reportAgainst *No report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Rhythm Pharmaceuticals, Inc. meeting?

461 Form N-PX filers reported votes at the meeting of 24 Jun 2026. On say-on-pay, 193 of 444 voted against management (43.5%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Rhythm Pharmaceuticals, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Rhythm Pharmaceuticals, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Rhythm Pharmaceuticals, Inc. with a meeting date within three days of 24 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.